Yahoo
OTC Markets OTCID USD

Halberd Corporation (HALB)

0.0019 +0.0001 (+5.56%)
As of October 30 at 4:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for HALB
  • Previous Close 0.0018
  • Open 0.0019
  • Bid 0.0014 x 16963700
  • Ask 0.0019 x 57878000
  • Day's Range 0.0019 - 0.0019
  • 52 Week Range 0.0006 - 0.0020
  • Volume 100
  • Avg. Volume 660,270
  • Market Cap (intraday) 1.344M
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Halberd Corporation, a biotech company, develops treatments for blood-borne and neurologic diseases. It offers treatments for post-traumatic stress disorder/chronic traumatic encephalopathy, cancer, and COVID-19. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

halberdcorporation.com

--

Full Time Employees

July 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HALB
26.67%
S&P 500 (^GSPC)
10.77%

1-Year Return

HALB
5.56%
S&P 500 (^GSPC)
10.67%

3-Year Return

HALB
72.86%
S&P 500 (^GSPC)
73.98%

5-Year Return

HALB
92.96%
S&P 500 (^GSPC)
62.70%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.94k

  • Net Income Avi to Common (ttm)

    -1.71M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.16k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: